Hub : Traits :

Tense / 'highly strung'

220 significantly associated models · 46 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 7715776 9571422 2 1 1.4e-07 4.8e-08 0.0291 84 RERE
2 1 173103273 175663031 2 1 1.1e-08 3.2e-09 1.0000 100 RABGAP1L
3 3 49615624 51077419 3 1 8.4e-08 1.1e-07 0.0507 86 CYB561D2
4 3 51616334 53015839 1 1 1.5e-07 6.5e-06 0.8440 100 WDR82
5 3 84317575 86808226 1 1 5.6e-09 7.3e-09 0.0164 83 CADM2
6 5 64115004 65711805 6 1 1.6e-09 1.1e-09 0.1430 94 CTC-534A2.2
7 6 147140769 148587096 1 1 2.9e-07 1.6e-06 0.1630 92 SAMD5
8 7 11553163 12967449 1 1 1.3e-07 2.9e-09 0.0023 74 TMEM106B
9 8 8092025 12966739 15 1 3.8e-13 5.7e-11 0.0063 83 AF131215.9
10 9 95502571 96913764 2 1 2.8e-08 2.9e-08 0.1260 92 RP11-165J3.6
11 16 30347731 31833122 8 1 4.2e-08 6.3e-08 0.3130 96 MYST1
12 17 34256906 35644076 1 1 3.0e-08 3.1e-04 0.5420 97 DHRS11
13 22 40946307 42614362 3 1 5.2e-08 3.9e-08 0.1570 93 L3MBTL2

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Bipolar Disorder (2018) 2.30 1 0 0.0 0.00 1.0e+00 WDR82
Bipolar Disorder or Schizophrenia 3.39 3 1 2.2 0.00 1.0e+00 L3MBTL2 RERE WDR82
Depressed Affect (Nagel 2018) 7.38 7 2 4.4 0.98 5.7e-05 L3MBTL2 MYST1 RABGAP1L RERE RP11-165J3.6 SAMD5 TMEM106B
Depression (Nagel 2018) 6.74 4 2 4.4 1.00 4.4e-03 CYB561D2 RERE RP11-165J3.6 TMEM106B
Intelligence (Savage-Jansen 2018) 2.45 2 1 2.2 0.00 1.0e+00 RABGAP1L WDR82
Neuroticism (Nagel 2018) 11.40 12 6 13.3 0.98 4.8e-08 AF131215.9 CADM2 CTC-534A2.2 CYB561D2 L3MBTL2 MYST1 RABGAP1L RERE RP11-165J3.6 SAMD5 TMEM106B WDR82
Schizophrenia (2018) 3.01 3 0 0.0 0.00 1.0e+00 L3MBTL2 RERE WDR82
Worry (Nagel 2018) 14.40 10 6 13.3 0.97 2.7e-06 CADM2 CTC-534A2.2 CYB561D2 L3MBTL2 MYST1 RABGAP1L RERE RP11-165J3.6 TMEM106B WDR82
Alzheimer’s Disease (including proxy) 2.77 1 0 0.0 0.00 1.0e+00 MYST1
Ulcerative Colitis (UC) 1.37 1 0 0.0 0.00 1.0e+00 CADM2
Major Depression (MDD) 4.32 1 0 0.0 0.00 1.0e+00 TMEM106B
Reaction Time 1.96 1 0 0.0 0.00 1.0e+00 RERE
Verbal and Numeric Reasoning (VNR) 2.61 1 0 0.0 0.00 1.0e+00 WDR82
Bipolar Disorder (2011) 3.71 1 0 0.0 0.00 1.0e+00 WDR82
Lupus 1.92 1 0 0.0 0.00 1.0e+00 AF131215.9
Neuroticism (2016) 8.28 3 1 2.2 0.00 1.0e+00 AF131215.9 L3MBTL2 WDR82
Schizophrenia (2014) 2.98 3 0 0.0 0.00 1.0e+00 L3MBTL2 RERE WDR82
Triglycerides 2.06 1 0 0.0 0.00 1.0e+00 MYST1
Blood Eosinophil Count 2.38 4 3 6.7 0.35 6.5e-01 CYB561D2 L3MBTL2 RERE WDR82
Blood Platelet Count 0.61 2 1 2.2 0.00 1.0e+00 CYB561D2 WDR82
Blood Red Count 1.83 4 4 8.9 -0.12 8.8e-01 CYB561D2 MYST1 RABGAP1L WDR82
Blood White Count 0.84 1 1 2.2 0.00 1.0e+00 RERE
Heel T-Score 3.45 3 2 4.4 0.00 1.0e+00 L3MBTL2 MYST1 RERE
BMI 3.16 6 2 4.4 -0.43 4.0e-01 CADM2 CYB561D2 MYST1 RABGAP1L TMEM106B WDR82
Height 1.52 5 5 11.1 0.68 2.0e-01 CYB561D2 RERE RP11-165J3.6 TMEM106B WDR82
Waist Hip Ratio (WHR) 2.32 2 2 4.4 0.00 1.0e+00 CYB561D2 WDR82
Systolic Blood Pressure 1.66 2 2 4.4 0.00 1.0e+00 CADM2 RERE
Smoking Status 3.92 3 2 4.4 0.00 1.0e+00 CADM2 RERE WDR82
Allergy or Eczema 4.13 2 2 4.4 0.00 1.0e+00 L3MBTL2 RERE
Cardiovascular Disease 1.88 2 1 2.2 0.00 1.0e+00 MYST1 RERE
Hypothyroidism (self reported) 2.06 1 0 0.0 0.00 1.0e+00 RERE
Respiratory disease 3.57 3 1 2.2 0.00 1.0e+00 L3MBTL2 RABGAP1L RERE
Lung FEV1/FVC ratio 0.95 1 0 0.0 0.00 1.0e+00 RERE
Lung FVC 2.16 2 2 4.4 0.00 1.0e+00 CYB561D2 MYST1
Neuroticism 9.32 11 5 11.1 0.99 1.7e-09 CADM2 CTC-534A2.2 CYB561D2 L3MBTL2 MYST1 RABGAP1L RERE RP11-165J3.6 SAMD5 TMEM106B WDR82
Chronotype (morning person) 3.30 3 1 2.2 0.00 1.0e+00 CYB561D2 DHRS11 SAMD5
Hair Pigment 0.15 1 1 2.2 0.00 1.0e+00 L3MBTL2
Tanning 0.62 2 1 2.2 0.00 1.0e+00 CADM2 WDR82
Hand grip strength (left) 1.41 1 0 0.0 0.00 1.0e+00 CADM2
Number of treatments/medications taken 3.93 3 0 0.0 0.00 1.0e+00 MYST1 RABGAP1L SAMD5
Sensitivity / hurt feelings 5.58 2 2 4.4 0.00 1.0e+00 AF131215.9 RP11-165J3.6
Frequency of depressed mood in last 2 weeks 7.42 5 0 0.0 0.99 9.2e-04 AF131215.9 RERE RP11-165J3.6 TMEM106B WDR82
Relative age of first facial hair 2.13 2 0 0.0 0.00 1.0e+00 CYB561D2 RABGAP1L
Systolic blood pressure, automated reading 2.51 2 2 4.4 0.00 1.0e+00 AF131215.9 RERE
Impedance of leg (right) 4.36 3 3 6.7 0.00 1.0e+00 AF131215.9 CADM2 CYB561D2
Leg fat-free mass (left) 2.05 3 2 4.4 0.00 1.0e+00 AF131215.9 CADM2 MYST1
Trunk fat percentage 2.49 3 2 4.4 0.00 1.0e+00 L3MBTL2 MYST1 RERE
Current tobacco smoking 2.37 1 0 0.0 0.00 1.0e+00 L3MBTL2
Fed-up feelings 4.81 2 1 2.2 0.00 1.0e+00 AF131215.9 DHRS11
Frequency of unenthusiasm / disinterest in last 2 weeks 4.81 3 0 0.0 0.00 1.0e+00 CYB561D2 RP11-165J3.6 TMEM106B
Taking other prescription medications 4.38 1 0 0.0 0.00 1.0e+00 L3MBTL2
Age when periods started (menarche) 2.23 2 0 0.0 0.00 1.0e+00 CYB561D2 WDR82
Heel bone mineral density (BMD) T-score, automated (left) 5.40 3 3 6.7 0.00 1.0e+00 AF131215.9 L3MBTL2 RERE
High blood pressure 2.70 3 1 2.2 0.00 1.0e+00 AF131215.9 MYST1 RERE
Hayfever, allergic rhinitis or eczema 3.79 2 1 2.2 0.00 1.0e+00 L3MBTL2 RERE
Medication: Levothyroxine sodium 2.33 2 0 0.0 0.00 1.0e+00 AF131215.9 RERE
Sitting height 0.77 1 0 0.0 0.00 1.0e+00 WDR82
Body mass index (BMI) 4.11 5 3 6.7 -0.67 2.1e-01 AF131215.9 CADM2 MYST1 RERE TMEM106B
Impedance of leg (left) 4.39 4 3 6.7 0.62 3.8e-01 AF131215.9 CADM2 CYB561D2 WDR82
Leg predicted mass (left) 2.02 3 2 4.4 0.00 1.0e+00 AF131215.9 CADM2 MYST1
Trunk fat mass 2.45 4 1 2.2 -0.46 5.4e-01 CADM2 L3MBTL2 MYST1 RERE
Waist circumference 2.93 2 2 4.4 0.00 1.0e+00 CADM2 MYST1
Number of incorrect matches in round 2.61 1 0 0.0 0.00 1.0e+00 MYST1
Past tobacco smoking 4.13 2 1 2.2 0.00 1.0e+00 CADM2 WDR82
Alcohol usually taken with meals 1.72 1 0 0.0 0.00 1.0e+00 RABGAP1L
Nervous feelings 11.89 6 4 8.9 0.98 8.4e-04 AF131215.9 CADM2 CYB561D2 L3MBTL2 MYST1 WDR82
Frequency of tenseness / restlessness in last 2 weeks 6.74 3 0 0.0 0.00 1.0e+00 RP11-165J3.6 TMEM106B WDR82
Forced vital capacity (FVC) 1.52 1 1 2.2 0.00 1.0e+00 MYST1
Heel bone mineral density (BMD) T-score, automated (right) 5.80 3 2 4.4 0.00 1.0e+00 AF131215.9 L3MBTL2 RERE
Ever unenthusiastic/disinterested for a whole week 3.28 1 0 0.0 0.00 1.0e+00 CYB561D2
Financial difficulties in last 2 years 1.78 1 0 0.0 0.00 1.0e+00 TMEM106B
Allergy 3.93 3 1 2.2 0.00 1.0e+00 CYB561D2 L3MBTL2 RERE
Pain all over the body in last month 2.92 1 0 0.0 0.00 1.0e+00 SAMD5
Illnesses of siblings 2.77 1 0 0.0 0.00 1.0e+00 MYST1
Neuroticism score 14.03 11 4 8.9 0.97 4.5e-07 AF131215.9 CADM2 CYB561D2 L3MBTL2 MYST1 RABGAP1L RERE RP11-165J3.6 SAMD5 TMEM106B WDR82
Weight 2.62 4 3 6.7 0.13 8.7e-01 AF131215.9 CADM2 MYST1 RABGAP1L
Impedance of arm (right) 4.52 6 3 6.7 0.77 7.0e-02 AF131215.9 CADM2 CYB561D2 L3MBTL2 TMEM106B WDR82
Arm fat percentage (right) 2.86 4 1 2.2 0.33 6.7e-01 AF131215.9 CADM2 MYST1 RERE
Trunk fat-free mass 1.76 3 1 2.2 0.00 1.0e+00 AF131215.9 CADM2 RABGAP1L
Hip circumference 2.99 4 2 4.4 0.17 8.3e-01 AF131215.9 CADM2 MYST1 RABGAP1L
Worrier / anxious feelings 12.02 8 4 8.9 0.97 4.4e-05 AF131215.9 CADM2 CYB561D2 L3MBTL2 MYST1 RP11-165J3.6 TMEM106B WDR82
Frequency of tiredness / lethargy in last 2 weeks 6.39 3 1 2.2 0.00 1.0e+00 L3MBTL2 RP11-165J3.6 TMEM106B
Forced expiratory volume in 1-second (FEV1) 1.95 1 1 2.2 0.00 1.0e+00 MYST1
Asthma 3.13 2 1 2.2 0.00 1.0e+00 L3MBTL2 RERE
Depression (self-reported) 5.84 2 0 0.0 0.00 1.0e+00 RERE TMEM106B
Forced expiratory volume in 1-second (FEV1), Best measure 2.31 1 1 2.2 0.00 1.0e+00 MYST1
Impedance of arm (left) 4.29 6 4 8.9 0.79 6.4e-02 AF131215.9 CADM2 CYB561D2 L3MBTL2 TMEM106B WDR82
Arm fat mass (right) 3.16 4 3 6.7 -0.21 7.9e-01 AF131215.9 CADM2 MYST1 RERE
Trunk predicted mass 1.73 3 1 2.2 0.00 1.0e+00 AF131215.9 CADM2 RABGAP1L
Standing height 1.47 5 3 6.7 0.67 2.1e-01 CYB561D2 RERE RP11-165J3.6 TMEM106B WDR82
Seen doctor (GP) for nerves, anxiety, tension or depression 8.31 5 2 4.4 0.98 3.1e-03 CTC-534A2.2 RP11-165J3.6 SAMD5 TMEM106B WDR82
Hair/balding pattern: Pattern 4 1.54 1 0 0.0 0.00 1.0e+00 RERE
Peak expiratory flow (PEF) 1.69 1 0 0.0 0.00 1.0e+00 AF131215.9
Medication: Paracetamol 3.34 1 1 2.2 0.00 1.0e+00 RABGAP1L
Headache pain in last month 2.43 1 0 0.0 0.00 1.0e+00 RABGAP1L
Hypothyroidism/myxoedema (self-reported) 2.75 2 1 2.2 0.00 1.0e+00 AF131215.9 RERE
High blood pressure (siblings) 2.93 2 0 0.0 0.00 1.0e+00 MYST1 TMEM106B
Forced vital capacity (FVC), Best measure 1.75 1 1 2.2 0.00 1.0e+00 MYST1
Body fat percentage 2.82 3 2 4.4 0.00 1.0e+00 L3MBTL2 MYST1 RERE
Leg fat percentage (right) 3.22 3 2 4.4 0.00 1.0e+00 AF131215.9 MYST1 RERE
Arm fat-free mass (right) 2.34 3 3 6.7 0.00 1.0e+00 AF131215.9 CADM2 MYST1
Comparative body size at age 10 6.21 7 5 11.1 -0.79 3.4e-02 AF131215.9 CADM2 CYB561D2 L3MBTL2 MYST1 RERE RP11-165J3.6
Worry too long after embarrassment 4.51 1 1 2.2 0.00 1.0e+00 AF131215.9
Seen a psychiatrist for nerves, anxiety, tension or depression 7.01 5 0 0.0 1.00 7.0e-05 CTC-534A2.2 L3MBTL2 SAMD5 TMEM106B WDR82
Wheeze or whistling in the chest in last year 4.41 2 0 0.0 0.00 1.0e+00 RERE RP11-165J3.6
Number of children fathered 2.25 1 0 0.0 0.00 1.0e+00 CADM2
Age at first live birth 1.84 1 0 0.0 0.00 1.0e+00 AF131215.9
Qualifications: College or University degree 1.18 1 0 0.0 0.00 1.0e+00 RABGAP1L
Medication for pain relief, constipation, heartburn 4.76 2 1 2.2 0.00 1.0e+00 RABGAP1L RP11-165J3.6
Mean time to correctly identify matches 1.89 1 0 0.0 0.00 1.0e+00 RERE
Whole body fat mass 2.82 4 1 2.2 0.41 5.9e-01 AF131215.9 CADM2 MYST1 RERE
Leg fat mass (right) 3.59 4 3 6.7 0.16 8.4e-01 AF131215.9 CADM2 MYST1 RERE
Arm predicted mass (right) 2.32 3 3 6.7 0.00 1.0e+00 AF131215.9 CADM2 MYST1
Pulse rate, automated reading 1.48 3 0 0.0 0.00 1.0e+00 CYB561D2 MYST1 RABGAP1L
Alcohol intake frequency. 2.66 2 1 2.2 0.00 1.0e+00 CADM2 L3MBTL2
Comparative height size at age 10 0.92 2 0 0.0 0.00 1.0e+00 RERE WDR82
Number of full sisters 3.02 1 0 0.0 0.00 1.0e+00 CADM2
Suffer from 'nerves' 9.42 5 2 4.4 0.61 2.7e-01 AF131215.9 CADM2 MYST1 RERE WDR82
Overall health rating 4.14 3 0 0.0 0.00 1.0e+00 CYB561D2 MYST1 RP11-165J3.6
Age at last live birth 2.44 1 0 0.0 0.00 1.0e+00 CADM2
Knee pain experienced in last month 2.87 1 0 0.0 0.00 1.0e+00 RABGAP1L
Hypertension (Self-reported) 2.78 3 1 2.2 0.00 1.0e+00 AF131215.9 MYST1 RERE
Smoking status: Previous 3.48 1 1 2.2 0.00 1.0e+00 CADM2
Forced expiratory volume in 1-second (FEV1), predicted 1.48 1 0 0.0 0.00 1.0e+00 CYB561D2
Whole body fat-free mass 1.93 3 2 4.4 0.00 1.0e+00 AF131215.9 CADM2 MYST1
Leg fat-free mass (right) 1.96 3 2 4.4 0.00 1.0e+00 AF131215.9 CADM2 MYST1
Arm fat percentage (left) 2.96 3 2 4.4 0.00 1.0e+00 AF131215.9 MYST1 RERE
Average weekly red wine intake 2.39 1 0 0.0 0.00 1.0e+00 CADM2
Mood swings 8.92 4 3 6.7 0.99 8.7e-03 AF131215.9 L3MBTL2 RP11-165J3.6 TMEM106B
Loneliness, isolation 4.77 2 0 0.0 0.00 1.0e+00 RERE TMEM106B
Long-standing illness, disability or infirmity 2.66 1 0 0.0 0.00 1.0e+00 TMEM106B
Mouth/teeth dental problems: Mouth ulcers 1.58 1 0 0.0 0.00 1.0e+00 CADM2
Medication for cholesterol 2.00 1 0 0.0 0.00 1.0e+00 MYST1
Asthma (self-reported) 2.93 1 1 2.2 0.00 1.0e+00 RERE
Forced expiratory volume in 1-second (FEV1), predicted percentage 2.54 1 1 2.2 0.00 1.0e+00 MYST1
Whole body water mass 1.93 3 2 4.4 0.00 1.0e+00 AF131215.9 CADM2 MYST1
Leg predicted mass (right) 1.96 3 2 4.4 0.00 1.0e+00 AF131215.9 CADM2 MYST1
Arm fat mass (left) 3.27 4 3 6.7 -0.11 8.9e-01 AF131215.9 CADM2 MYST1 RERE
Number of self-reported non-cancer illnesses 3.73 2 0 0.0 0.00 1.0e+00 L3MBTL2 TMEM106B
Miserableness 8.10 3 3 6.7 0.00 1.0e+00 AF131215.9 RP11-165J3.6 TMEM106B
Guilty feelings 4.44 1 1 2.2 0.00 1.0e+00 AF131215.9
Medication: Blood pressure 2.21 2 0 0.0 0.00 1.0e+00 AF131215.9 MYST1
High cholesterol (Self-reported) 1.79 1 0 0.0 0.00 1.0e+00 MYST1
Medication: Bendroflumethiazide 2.80 1 1 2.2 0.00 1.0e+00 AF131215.9
Medication: Paracetamol 2.71 1 1 2.2 0.00 1.0e+00 RABGAP1L
Ever smoked 3.32 2 1 2.2 0.00 1.0e+00 CADM2 WDR82
Basal metabolic rate 2.10 4 3 6.7 -0.25 7.5e-01 AF131215.9 CADM2 MYST1 RABGAP1L
Leg fat percentage (left) 3.15 4 2 4.4 0.60 4.0e-01 AF131215.9 CADM2 MYST1 RERE
Arm fat-free mass (left) 2.29 4 3 6.7 -0.14 8.6e-01 AF131215.9 CADM2 MYST1 RABGAP1L
Number of operations (self-reported) 3.21 1 0 0.0 0.00 1.0e+00 SAMD5
Average weekly beer plus cider intake 2.60 1 0 0.0 0.00 1.0e+00 AF131215.9
Irritability 8.76 5 2 4.4 0.99 1.8e-03 AF131215.9 L3MBTL2 MYST1 SAMD5 TMEM106B
Risk taking 5.03 2 1 2.2 0.00 1.0e+00 AF131215.9 CADM2
Diastolic blood pressure, automated reading 3.33 3 2 4.4 0.00 1.0e+00 AF131215.9 MYST1 RERE
Vascular/heart problems diagnosed by doctor 2.58 3 1 2.2 0.00 1.0e+00 AF131215.9 MYST1 RERE
Cholesterol lowering medication 1.46 1 0 0.0 0.00 1.0e+00 MYST1
Pain experienced in last month 2.99 3 0 0.0 0.00 1.0e+00 MYST1 RABGAP1L RP11-165J3.6
Impedance of whole body 4.97 6 3 6.7 0.83 3.9e-02 AF131215.9 CADM2 CYB561D2 L3MBTL2 TMEM106B WDR82
Leg fat mass (left) 3.50 4 3 6.7 0.12 8.8e-01 AF131215.9 CADM2 MYST1 RERE
Arm predicted mass (left) 2.43 4 3 6.7 -0.23 7.7e-01 AF131215.9 CADM2 MYST1 RABGAP1L

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 6 0.172 1.7
GTEx Adipose Visceral Omentum 4 0.196 1.8
GTEx Adrenal Gland 4 0.275 1.7
GTEx Artery Aorta 6 0.202 1.7
GTEx Artery Coronary 1 0.085 1.8
GTEx Artery Tibial 7 0.186 1.7
GTEx Brain Caudate basal ganglia 0 0.000 1.8
GTEx Brain Cerebellar Hemisphere 2 0.134 1.8
GTEx Brain Cerebellum 1 0.050 1.7
GTEx Brain Cortex 1 0.097 1.8
GTEx Brain Frontal Cortex BA9 1 0.108 1.8
GTEx Brain Hippocampus 0 0.000 1.9
GTEx Brain Hypothalamus 0 0.000 1.6
GTEx Brain Nucleus accumbens basal ganglia 0 0.000 1.6
GTEx Brain Putamen basal ganglia 2 0.321 1.7
GTEx Breast Mammary Tissue 4 0.203 1.8
GTEx Breast Mammary Tissue (Male) 1 0.084 1.7
GTEx Breast Mammary Tissue (Female) 3 0.182 1.7
GTEx Cells EBV-transformed lymphocytes 2 0.141 1.8
GTEx Cells Transformed fibroblasts 3 0.071 1.6
GTEx Colon Sigmoid 4 0.274 1.7
GTEx Colon Transverse 6 0.291 1.8
GTEx Esophagus Gastroesophageal Junction 3 0.208 1.8
GTEx Esophagus Mucosa 8 0.241 1.7
GTEx Esophagus Muscularis 6 0.186 1.8
GTEx Heart Atrial Appendage 3 0.190 1.8
GTEx Heart Left Ventricle 4 0.261 1.8
GTEx Liver 0 0.000 1.7
GTEx Lung 8 0.278 1.8
GTEx Muscle Skeletal 3 0.104 1.6
GTEx Nerve Tibial 7 0.162 1.7
GTEx Ovary 0 0.000 1.9
GTEx Pancreas 3 0.184 1.7
GTEx Pituitary 3 0.269 1.9
GTEx Prostate 2 0.240 1.7
GTEx Skin Not Sun Exposed Suprapubic 6 0.244 1.8
GTEx Skin Sun Exposed Lower leg 8 0.220 1.7
GTEx Small Intestine Terminal Ileum 1 0.217 2.1
GTEx Spleen 2 0.142 1.9
GTEx Stomach 3 0.206 1.8
GTEx Testis 6 0.190 1.8
GTEx Thyroid 8 0.200 1.7
GTEx Uterus 4 0.705 1.8
GTEx Vagina 1 0.157 1.7
GTEx Whole Blood 1 0.050 1.7
METSIM Adipose 7 0.152 1.6
NTR Blood 4 0.167 1.6
ROSMAP Brain Pre-frontal Cortex 16 0.364 1.8
YFS Blood 5 0.108 1.5
CommonMind Brain Pre-frontal Cortex 3 0.056 1.6
The Cancer Genome Atlas Bladder Urothelial Carcinoma 2 0.121 1.6
The Cancer Genome Atlas Breast Invasive Carcinoma 3 0.068 1.5
The Cancer Genome Atlas Cervical Squamous Cell Carcinoma 0 0.000 1.6
The Cancer Genome Atlas Colon Adenocarcinoma 1 0.048 1.6
The Cancer Genome Atlas Esophageal Carcinoma 2 0.292 1.9
The Cancer Genome Atlas Glioblastoma Multiforme 0 0.000 1.6
The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma 4 0.147 1.6
The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma 1 0.024 1.5
The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma 2 0.098 1.6
The Cancer Genome Atlas Brain Lower Grade Glioma 3 0.070 1.5
The Cancer Genome Atlas Liver Hepatocellular Carcinoma 3 0.271 1.6
The Cancer Genome Atlas Lung Adenocarcinoma 2 0.068 1.5
The Cancer Genome Atlas Lung Squamous Cell Carcinoma 2 0.080 1.6
The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma 2 0.126 1.5
The Cancer Genome Atlas Pancreatic Adenocarcinoma 0 0.000 1.6
The Cancer Genome Atlas Pheochromocytoma and Paraganglioma 3 0.226 1.7
The Cancer Genome Atlas Prostate Adenocarcinoma 1 0.022 1.6
The Cancer Genome Atlas Rectum Adenocarcinoma 0 0.000 1.5
The Cancer Genome Atlas Soft Tissue Sarcoma 0 0.000 1.5
The Cancer Genome Atlas Skin Cutaneous Melanoma 0 0.000 1.5
The Cancer Genome Atlas Stomach Adenocarcinoma 1 0.059 1.6
The Cancer Genome Atlas Testicular Germ Cell Tumors 2 0.156 1.7
The Cancer Genome Atlas Thyroid Carcinoma 3 0.058 1.5
The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma 0 0.000 1.5